Article
A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
Journal of human genetics - 1 Jun 2009
Dobrowolski Steven F, Borski K, Ellingson C C, Koch R, Levy H L, Naylor E W
Abstract excerpt
Phenylketonuria (PKU) is an autosomal recessive defect in hepatic metabolism of phenylalanine, which is secondary to mutations in the phenylalanine hydroxylase (PAH) gene. Sixty-seven ethnically Polish PKU patients, followed at the Outpatient Department of Pediatrics and Developmental Medicine in Poznan, Poland, were assessed for mutations in the PAH gene. Two mutations were identified in 61 of 67 patients and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
